223 related articles for article (PubMed ID: 26503558)
1. Cucurbitacins: A Systematic Review of the Phytochemistry and Anticancer Activity.
Cai Y; Fang X; He C; Li P; Xiao F; Wang Y; Chen M
Am J Chin Med; 2015; 43(7):1331-50. PubMed ID: 26503558
[TBL] [Abstract][Full Text] [Related]
2. Potential of cucurbitacin as an anticancer drug.
Li Y; Li Y; Yao Y; Li H; Gao C; Sun C; Zhuang J
Biomed Pharmacother; 2023 Dec; 168():115707. PubMed ID: 37862969
[TBL] [Abstract][Full Text] [Related]
3. Apoptotic and antimetastatic effect of cucurbitacins in cancer: recent trends and advancement.
Kumar A; Sharma B; Sharma U; Parashar G; Parashar NC; Rani I; Ramniwas S; Kaur S; Haque S; Tuli HS
Naunyn Schmiedebergs Arch Pharmacol; 2023 Sep; 396(9):1867-1878. PubMed ID: 37010571
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic effects of natural and semisynthetic cucurbitacins on lung cancer cell line A549.
Silva IT; Geller FC; Persich L; Dudek SE; Lang KL; Caro MS; Durán FJ; Schenkel EP; Ludwig S; Simões CM
Invest New Drugs; 2016 Apr; 34(2):139-48. PubMed ID: 26780083
[TBL] [Abstract][Full Text] [Related]
5. ANTITUMOR AND APOPTOTIC EFFECTS OF CUCURBITACIN A IN A-549 LUNG CARCINOMA CELLS IS MEDIATED VIA G2/M CELL CYCLE ARREST AND M-TOR/PI3K/AKT SIGNALLING PATHWAY.
Wang WD; Liu Y; Su Y; Xiong XZ; Shang D; Xu JJ; Liu HJ
Afr J Tradit Complement Altern Med; 2017; 14(2):75-82. PubMed ID: 28573224
[TBL] [Abstract][Full Text] [Related]
6. Cucurbitacins as inducers of cell death and a rich source of potential anticancer compounds.
Ríos JL; Andújar I; Escandell JM; Giner RM; Recio MC
Curr Pharm Des; 2012; 18(12):1663-76. PubMed ID: 22443631
[TBL] [Abstract][Full Text] [Related]
7. Biological activities and potential molecular targets of cucurbitacins: a focus on cancer.
Chen X; Bao J; Guo J; Ding Q; Lu J; Huang M; Wang Y
Anticancer Drugs; 2012 Sep; 23(8):777-87. PubMed ID: 22561419
[TBL] [Abstract][Full Text] [Related]
8. Cucurbitacins as Anticancer Agents: A Patent Review.
Hussain H; Green IR; Saleem M; Khattak KF; Irshad M; Ali M
Recent Pat Anticancer Drug Discov; 2019; 14(2):133-143. PubMed ID: 30451116
[TBL] [Abstract][Full Text] [Related]
9. Cucurbitacin: ancient compound shedding new light on cancer treatment.
Lee DH; Iwanski GB; Thoennissen NH
ScientificWorldJournal; 2010 Mar; 10():413-8. PubMed ID: 20209387
[TBL] [Abstract][Full Text] [Related]
10. Use of cucurbitacins for lung cancer research and therapy.
Liu M; Yan Q; Peng B; Cai Y; Zeng S; Xu Z; Yan Y; Gong Z
Cancer Chemother Pharmacol; 2021 Jul; 88(1):1-14. PubMed ID: 33825035
[TBL] [Abstract][Full Text] [Related]
11. Cucurbitacin IIb from Ibervillea sonorae Induces Apoptosis and Cell Cycle Arrest via STAT3 Inhibition.
Torres-Moreno H; Marcotullio MC; Velazquez C; Arenas-Luna VM; Hernández-Gutiérrez S; Robles-Zepeda RE
Anticancer Agents Med Chem; 2020; 20(10):1188-1196. PubMed ID: 32294048
[TBL] [Abstract][Full Text] [Related]
12. Cucurbitacin IIa: A review of phytochemistry and pharmacology.
Zeng Y; Wang J; Huang Q; Ren Y; Li T; Zhang X; Yao R; Sun J
Phytother Res; 2021 Aug; 35(8):4155-4170. PubMed ID: 33724593
[TBL] [Abstract][Full Text] [Related]
13. Cucurbitacins as Potent Chemo-Preventive Agents: Mechanistic Insight and Recent Trends.
Tuli HS; Rath P; Chauhan A; Ranjan A; Ramniwas S; Sak K; Aggarwal D; Kumar M; Dhama K; Lee EHC; Yap KC; Capinpin SM; Kumar AP
Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671442
[TBL] [Abstract][Full Text] [Related]
14. Cucurbitacin IIb induces apoptosis and cell cycle arrest through regulating EGFR/MAPK pathway.
Liang Y; Zhang T; Ren L; Jing S; Li Z; Zuo P; Li T; Wang Y; Zhang J; Wei Z
Environ Toxicol Pharmacol; 2021 Jan; 81():103542. PubMed ID: 33161110
[TBL] [Abstract][Full Text] [Related]
15. The anticancer activity of propolis.
Sawicka D; Car H; Borawska MH; Nikliński J
Folia Histochem Cytobiol; 2012 Apr; 50(1):25-37. PubMed ID: 22532133
[TBL] [Abstract][Full Text] [Related]
16. Cucurbitacins and the Immune System: Update in Research on Anti- inflammatory, Antioxidant, and Immunomodulatory Mechanisms.
Silvestre GFG; de Lucena RP; da Silva Alves H
Curr Med Chem; 2022; 29(21):3774-3789. PubMed ID: 34994307
[TBL] [Abstract][Full Text] [Related]
17. Anticancer Effects of Herbal Medicine Compounds and Novel Formulations: a Literature Review.
Abdulridha MK; Al-Marzoqi AH; Al-Awsi GRL; Mubarak SMH; Heidarifard M; Ghasemian A
J Gastrointest Cancer; 2020 Sep; 51(3):765-773. PubMed ID: 32140897
[TBL] [Abstract][Full Text] [Related]
18. Synergistic Antiproliferative Effects of a New Cucurbitacin B Derivative and Chemotherapy Drugs on Lung Cancer Cell Line A549.
Marostica LL; Silva IT; Kratz JM; Persich L; Geller FC; Lang KL; Caro MS; Durán FJ; Schenkel EP; Simões CM
Chem Res Toxicol; 2015 Oct; 28(10):1949-60. PubMed ID: 26372186
[TBL] [Abstract][Full Text] [Related]
19. Anti-proliferative effect of 23,24-dihydrocucurbitacin F on human prostate cancer cells through induction of actin aggregation and cofilin-actin rod formation.
Ren S; Ouyang DY; Saltis M; Xu LH; Zha QB; Cai JY; He XH
Cancer Chemother Pharmacol; 2012 Sep; 70(3):415-24. PubMed ID: 22814677
[TBL] [Abstract][Full Text] [Related]
20. Cucurbitacins as potential anticancer agents: new insights on molecular mechanisms.
Varela C; Melim C; Neves BG; Sharifi-Rad J; Calina D; Mamurova A; Cabral C
J Transl Med; 2022 Dec; 20(1):630. PubMed ID: 36585670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
